Christie J M, Chapel H, Chapman R W, Rosenberg W M
Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK.
Hepatology. 1999 Oct;30(4):1037-44. doi: 10.1002/hep.510300403.
How Hepatitis C Virus (HCV) causes persistent infection is unknown. One hypothesis is that HCV evades the host immune response through mutation in immune epitopes. We have investigated mutations in the HCV genome to see if they cluster within immune epitopes; and we have studied the effect of antibody deficiency on mutation rates. We studied patients with chronic hepatitis C, 3 with antibody deficiency and 3 with normal immunity. Regions of the core and envelope genes of HCV, encoding cytotoxic (CTL), and B cell epitopes were sequenced at 2 time points, 2 years apart. The diversity of quasispecies increased with time. The HCV genetic mutation rate was higher than previously predicted. The cryptic nucleotide mutation rate in core was similar to that observed in envelope, suggesting that the error rate of the HCV RNA polymerase is similar in both regions. In contrast, the coding mutation rate was decreased in core and increased in envelope. No genetic mutation was seen in any of the core CTL epitopes despite detectable cellular responses. All patients had mutations within a previously described envelope CTL epitope but did not exhibit immune responses to either index or mutated peptides. There was no difference in mutation rates in any cellular or humoral epitopes between patients with antibody deficiency and normal immunity. Thus we have found no evidence that mutations were selected by T-lymphocytes or antibodies. These findings implicate alternative virus-host interactions in the selection of HCV mutations.
丙型肝炎病毒(HCV)如何导致持续感染尚不清楚。一种假说认为,HCV通过免疫表位的突变逃避宿主免疫反应。我们研究了HCV基因组中的突变,以观察它们是否聚集在免疫表位内;并且我们研究了抗体缺陷对突变率的影响。我们研究了慢性丙型肝炎患者,3例有抗体缺陷,3例免疫正常。在相隔2年的两个时间点对HCV核心基因和包膜基因中编码细胞毒性(CTL)和B细胞表位的区域进行测序。准种的多样性随时间增加。HCV基因突变率高于先前预测。核心区的隐蔽核苷酸突变率与包膜区观察到的相似,表明HCV RNA聚合酶在这两个区域的错误率相似。相比之下,核心区的编码突变率降低,包膜区的编码突变率升高。尽管可检测到细胞反应,但在任何核心CTL表位中均未发现基因突变。所有患者在先前描述的包膜CTL表位内均有突变,但对索引肽或突变肽均未表现出免疫反应。抗体缺陷患者和免疫正常患者在任何细胞或体液表位的突变率均无差异。因此,我们没有发现证据表明突变是由T淋巴细胞或抗体选择的。这些发现暗示了在HCV突变选择中存在其他病毒-宿主相互作用。